New Prodrugs to Fight Sleeping Sickness
Author Information
Author(s): Ruda Gian Filippo, Alibu Vincent P, Mitsos Christos, Bidet Olivier, Kaiser Marcel, Brun Reto, Barrett Michael P, Gilbert Ian H
Primary Institution: University of Dundee
Hypothesis
Can phosphate prodrugs enhance the efficacy of inhibitors against Trypanosoma brucei?
Conclusion
The study successfully synthesized several classes of phosphate prodrugs that showed improved activity against Trypanosoma brucei.
Supporting Evidence
- Most prodrugs inhibited the growth of Trypanosoma brucei.
- The activity of the prodrugs was related to their stability in aqueous buffer.
- Compounds with longer half-lives were more effective against the parasites.
Takeaway
Scientists made new medicines that can better fight a disease called sleeping sickness by helping the medicine get inside the bad germs.
Methodology
The study involved synthesizing five classes of prodrugs and evaluating their stability and activity against Trypanosoma brucei.
Limitations
The prodrugs had relatively short half-lives in aqueous phosphate buffer, which may limit their effectiveness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website